Screening survey and cohort construction of HTLV-1 in Ishigaki Island

Screening survey and cohort construction of HTLV-1 in Ishigaki Island - Screening survey of HTLV-1 in Ishigaki Island

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030638

Enrollment

300

Registered

2018-01-01

Start date

2015-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human T-cell Leukemia Virus Type I (HTLV-1) carrier

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy islanders attending medical check-ups and outpatients (i.e., patients with diabetes) at Kariyushi Hospital

Exclusion criteria

Exclusion criteria: Outpatients with serious diseases including malignancies

Design outcomes

Primary

Measure	Time frame
prevalence rate of anti-HTLV-1 antibody	—

Secondary

Measure	Time frame
prevalence rate of anti-parasite antibodies and distribution pattern of HTLV-1	—

Countries

Japan

Contacts

Public ContactTakuya Fukushima

University of the Ryukyus School of Health Sciences, Faculty of Medicine

fukutaku@med.u-ryukyu.ac.jp+81-98-895-3331

Outcome results